Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Paclitaxel vs Nab-paclitaxel or Ixabepilone +/- Bevacizumab in Breast Cancer
NCT00785291Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2008
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of paclitaxel, ixabepilone in breast cancer, sponsored by National Cancer Institute. Started Oct 2008; status: completed.
02
Drugs
paclitaxelixabepilone
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00785291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00785291.